ATC code H03
| ATC codes |
|---|
| H Systemic hormonal preparations, excluding sex hormones and insulins |
| H01 Pituitary and hypothalamic hormones and analogues |
| H02 Corticosteroids for systemic use |
| H03 Thyroid therapy |
| H04 Pancreatic hormones |
| H05 Calcium homeostasis |
|
|
ATC code H03 Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup H03 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH03.[2]National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H03A Thyroid preparations
H03AA Thyroid hormones
- H03AA01 Levothyroxine sodium
- H03AA02 Liothyronine sodium
- H03AA03 Combinations of levothyroxine and liothyronine
- H03AA04 Tiratricol
- H03AA05 Thyroid gland preparations
H03B Antithyroid preparations
H03BA Thiouracils
- H03BA01 Methylthiouracil
- H03BA02 Propylthiouracil
- H03BA03 Benzylthiouracil
H03BB Sulphur-containing imidazole derivatives
- H03BB01 Carbimazole
- H03BB02 Thiamazole
- H03BB52 Thiamazole, combinations
H03BC Perchlorates
- H03BC01 Potassium perchlorate
H03BX Other antithyroid preparations
- H03BX01 Diiodotyrosine
- H03BX02 Dibromotyrosine
References
- ↑ "ATC/DDD Index 2016: code H03". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2016: code QH03". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia - version of the 4/8/2013. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.